Providers must carefully consider treatment options to align with patient preference.
Vishal Patel, MD
Advertisement
Articles by Vishal Patel, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
2
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
3
Michael Cookson, MD, reacts to Anktiva’s expanded approval in NMIBC
4
ESMO 2026: Key presentations across genitourinary oncology
5